ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional

A Study to Investigate Efficacy and Safety of TOUR006 in Participants 18 to 80 Years of Age With Thyroid Eye Disease

ClinicalTrials.gov ID: NCT06088979

Public ClinicalTrials.gov record NCT06088979. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 17, 2026, 11:10 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter Phase 2b Randomized, Double-Masked, Placebo-Controlled Dose-Ranging Study of TOUR006 in Participants With Thyroid Eye Disease

Study identification

NCT ID
NCT06088979
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Tourmaline Bio, Inc.
Industry
Enrollment
79 participants

Conditions and interventions

Interventions

  • Placebo Other
  • TOUR006 - 20 MG Drug
  • TOUR006 - 50 MG Drug

Other · Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 18, 2024
Primary completion
Aug 31, 2026
Completion
Aug 31, 2027
Last update posted
Apr 22, 2026

2024 – 2027

United States locations

U.S. sites
15
U.S. states
11
U.S. cities
15
Facility City State ZIP Site status
Catalina Eye Care - Site 840-121 Tucson Arizona 85712
Foothill Eye Institute - Site 840-116 Pasadena California 91107
University of California Davis Eye Center - Site 840-119 Sacramento California 95817
The Pacific Center for Oculofacial and Aesthetic Plastic Surgery - Site 840-122 San Francisco California 94115
UC Hospital Sue Anschulz-Rodgers Eye Center - Site 840-101 Aurora Colorado 80045
Bascom Palmer Eye Institute - Site 840-115 Miami Florida 33136
Ophthalmic Consultants of Boston - Site 840-128 Boston Massachusetts 02114
Kahana Oculoplastic and Orbital Surgery - Site 840-112 Livonia Michigan 48152
Ophthalmic Plastic, Reconstructive, Orbital & Cosmetic Surgery - Site 840-123 Las Vegas Nevada 89144
Hackensack University Medical Center - Site 840-105 Hackensack New Jersey 07601
Columbia University - Site 840-125 New York New York 10032
Academy of Diabetes, Thyroid, and Endocrine - Site 840-129 El Paso Texas 79935
DCT Fort Worth Research Center - Site 840-133 Fort Worth Texas 76132
Sun Research Institute - Site 840-120 San Antonio Texas 78215
University of West Virginia - Site 840-113 Morgantown West Virginia 26506

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 21 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06088979, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 22, 2026 · Synced May 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06088979 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →